Ban-Yew Bernard Yaw
Vorstandsvorsitzender bei Asiante Capital Management Sdn. Bhd.
Profil
Ban-Yew Bernard Yaw is currently the Chief Executive Officer at Asiante Capital Management Sdn.
Bhd.
Prior to this, he was the President & Chief Executive Officer at NRP Stone, Inc. and an Independent Non-Executive Director at Real Nutriceutical Group Ltd.
from 2009 to 2012.
Mr. Yaw received his undergraduate degree from Oral Roberts University in 1985.
Aktive Positionen von Ban-Yew Bernard Yaw
Unternehmen | Position | Beginn |
---|---|---|
Asiante Capital Management Sdn. Bhd. | Vorstandsvorsitzender | 19.08.2011 |
Ehemalige bekannte Positionen von Ban-Yew Bernard Yaw
Unternehmen | Position | Ende |
---|---|---|
REAL NUTRICEUTICAL GROUP LIMITED | Direktor/Vorstandsmitglied | 01.09.2012 |
NRP STONE INC. | Präsident | - |
Ausbildung von Ban-Yew Bernard Yaw
Oral Roberts University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
NRP STONE INC. | Producer Manufacturing |
Private Unternehmen | 2 |
---|---|
Real Nutriceutical Group Ltd.
Real Nutriceutical Group Ltd. Pharmaceuticals: OtherHealth Technology Real Nutriceutical Group Ltd. operates as an investment holding company, which engages in the manufacture and sale of health & nutritional supplements and pharmaceutical products. It operates through the following segments: Health and Nutritional Supplements segment, Health Drinks and Pharmaceutical Products segment. The Health and Nutritional Supplements segment is engaged in the manufacture and sales of health and nutritional supplements. Its products include amino acids products, nutrient products and imported products. The Health Drinks segment is engaged in the manufacture and sales of health drinks. Its products include herbal tea products and amino acid drinks. The Pharmaceutical Products segment is engaged in the manufacture and sales of pharmaceutical products. Its main products include eye drops and antineoplastic drugs. The company was founded by Fu Cai Wang in 1997 and is headquartered in Hong Kong. | Health Technology |
Asiante Capital Management Sdn. Bhd. |